Maravai Lifesciences Holdings Inc (MRVI)
Cost of Revenue
$136.53M
TTM · Period ending: · USD
MRVI Cost of Revenue
Latest reported$136.53Mperiod ending
Latest reported$136.53Mperiod ending
MRVI TTM Cost of Revenue ($74.08M → $136.53M)
TTM cost of revenue
High-resolution chart · PNG
MRVI cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 136,527,000 | |
| 145,364,000 | |
| 152,353,000 | |
| 152,173,000 | |
| 153,024,000 | |
| 151,666,000 | |
| 150,876,000 | |
| 148,540,000 | |
| 148,400,000 | |
| 153,402,000 | |
| 148,743,000 | |
| 166,888,000 | |
| 168,378,000 | |
| 162,601,000 | |
| 168,957,000 | |
| 156,337,000 | |
| 150,382,000 | |
| 150,697,000 | |
| 142,056,000 | |
| 124,818,000 | |
| 112,357,000 | |
| 95,743,000 | |
| 79,649,000 | |
| 74,084,000 |